Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Actividentity Corp (MM) (ACTI)
Actividentity Corp (MM) (ACTI) News

ACTI

Actividentity Corp (MM) (ACTI)

Actividentity Corp (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACTI

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
02/15/2018	4:10AM	GlobeNewswire	Active Biotech announces rights issue of approximately SEK 48 million	NASDAQ:ACTI	Actividentity Corp (MM)
02/15/2018	2:40AM	GlobeNewswire	NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING	NASDAQ:ACTI	Actividentity Corp (MM)
02/15/2018	2:31AM	GlobeNewswire	Active Biotech carries out rights issue	NASDAQ:ACTI	Actividentity Corp (MM)
02/15/2018	2:30AM	GlobeNewswire	Active Biotech AB Year-end report January - December 2017	NASDAQ:ACTI	Actividentity Corp (MM)
12/20/2017	9:00AM	GlobeNewswire	Active Biotech provides updated information about the company's financial position	NASDAQ:ACTI	Actividentity Corp (MM)
12/07/2017	1:00PM	GlobeNewswire	Active Biotech provides updated information about the company's financial position - the company currently lacks funding to e...	NASDAQ:ACTI	Actividentity Corp (MM)
12/01/2017	7:00AM	GlobeNewswire	Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS	NASDAQ:ACTI	Actividentity Corp (MM)
11/17/2017	2:30AM	GlobeNewswire	Active Biotech's election committee appointed	NASDAQ:ACTI	Actividentity Corp (MM)
11/09/2017	2:30AM	GlobeNewswire	Active Biotech AB - Interim report January - September 2017	NASDAQ:ACTI	Actividentity Corp (MM)
10/19/2017	8:00AM	GlobeNewswire	Active Biotech's partner Teva presents new data on laquinimod for the treatment of multiple sclerosis at 7th joint ECTRIMS-AC...	NASDAQ:ACTI	Actividentity Corp (MM)
08/10/2017	2:30AM	GlobeNewswire	Active Biotech AB - Interim report January - June 2017	NASDAQ:ACTI	Actividentity Corp (MM)
06/19/2017	9:30AM	GlobeNewswire	Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017	NASDAQ:ACTI	Actividentity Corp (MM)
06/16/2017	2:30AM	GlobeNewswire	Annual General Meeting of Active Biotech AB	NASDAQ:ACTI	Actividentity Corp (MM)
05/18/2017	8:30AM	GlobeNewswire	Annual Report 2016 Active Biotech AB (publ)	NASDAQ:ACTI	Actividentity Corp (MM)
05/17/2017	2:30AM	GlobeNewswire	Active Biotech: Notice of Annual General Meeting of Shareholders	NASDAQ:ACTI	Actividentity Corp (MM)
05/05/2017	2:00PM	GlobeNewswire	Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint	NASDAQ:ACTI	Actividentity Corp (MM)
04/27/2017	2:30AM	GlobeNewswire	Active Biotech: Interim report January - March 2017	NASDAQ:ACTI	Actividentity Corp (MM)
04/12/2017	7:30AM	GlobeNewswire	Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple myeloma	NASDAQ:ACTI	Actividentity Corp (MM)
02/16/2017	2:30AM	GlobeNewswire	Active Biotech AB Year-end report January - December 2016	NASDAQ:ACTI	Actividentity Corp (MM)
01/09/2017	7:08AM	GlobeNewswire Inc.	The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma	NASDAQ:ACTI	Actividentity Corp (MM)
01/09/2017	7:00AM	GlobeNewswire	The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma	NASDAQ:ACTI	Actividentity Corp (MM)
12/30/2016	2:36AM	GlobeNewswire Inc.	Number of shares and votes in Active Biotech	NASDAQ:ACTI	Actividentity Corp (MM)
12/30/2016	2:30AM	GlobeNewswire	Number of shares and votes in Active Biotech	NASDAQ:ACTI	Actividentity Corp (MM)
12/12/2016	11:31AM	GlobeNewswire	Active Biotech's rights issue completed	NASDAQ:ACTI	Actividentity Corp (MM)
11/22/2016	9:05AM	GlobeNewswire	Active Biotech's election committee appointed	NASDAQ:ACTI	Actividentity Corp (MM)
11/18/2016	9:15AM	GlobeNewswire	Prospectus relating to Active Biotech's rights issue published	NASDAQ:ACTI	Actividentity Corp (MM)
11/11/2016	1:01PM	GlobeNewswire	Active Biotech carries out rights issue of approximately SEK 55 million	NASDAQ:ACTI	Actividentity Corp (MM)
11/11/2016	1:00PM	GlobeNewswire	Active Biotech AB Interim report January - September 2016	NASDAQ:ACTI	Actividentity Corp (MM)
10/26/2016	2:35AM	GlobeNewswire Inc.	Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology	NASDAQ:ACTI	Actividentity Corp (MM)